Cargando…

The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden

Colorectal Peritoneal metastases (CPM) develop in 15% of colorectal cancers. Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS & HIPEC) is the current standard of care in selected patients with limited resectable CPM. Despite selection using known prognostic factors survival is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallam, Sally, Stockton, Joanne, Bryer, Claire, Whalley, Celina, Pestinger, Valerie, Youssef, Haney, Beggs, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641117/ https://www.ncbi.nlm.nih.gov/pubmed/33144643 http://dx.doi.org/10.1038/s41598-020-75844-6

Ejemplares similares

Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden
por: Stockton, Joanne D., et al.
Publicado: (2021)

Meta‐analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
por: Hallam, S., et al.
Publicado: (2019)

Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
por: Pestinger, Valerie, et al.
Publicado: (2020)

Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
por: Pestinger, Valerie, et al.
Publicado: (2020)

Whole-genome methylation analysis of benign and malignant colorectal tumours
por: Beggs, Andrew D, et al.
Publicado: (2013)

Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer
por: Wanigasooriya, Kasun, et al.
Publicado: (2022)

MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in Colorectal Cancer Organoids
por: Pickles, Oliver J., et al.
Publicado: (2023)

Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA
por: Whalley, Celina, et al.
Publicado: (2021)

Low Preoperative Serum Albumin Levels Are Associated With Impaired Outcome After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
por: Seretis, Charalampos, et al.
Publicado: (2020)

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
por: Hübner, Martin, et al.
Publicado: (2023)

Treatment of Patients with Malignant Peritoneal Mesothelioma
por: Li, Claire Y., et al.
Publicado: (2022)

Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study
por: Beggs, Andrew D., et al.
Publicado: (2018)

Molecular characterization of colorectal cancer related peritoneal metastatic disease
por: Lenos, Kristiaan J., et al.
Publicado: (2022)

Diffuse malignant peritoneal mesothelioma mimicking ovarian cancer.
por: Houssaini, Zaynab Iraqi, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition and Somatic Alteration in Colorectal Cancer with and without Peritoneal Carcinomatosis
por: Shelygin, Y. A., et al.
Publicado: (2014)

Management of Peritoneal Malignancies
por: Berri, Richard N., et al.
Publicado: (2019)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?
por: Zappa, Magaly, et al.
Publicado: (2017)

The Opium Treatment of Peritonitis
por: Stockton, Charles G.
Publicado: (1908)

Peritoneal or mesenteric tumours revealing histiocytosis
por: Cohen-Aubart, Fleur, et al.
Publicado: (2021)

Case report: acute bowel obstruction with an isolated transition point in peritoneal dialysis patients; a presentation of encapsulating peritoneal sclerosis?
por: Ghazan-Shahi, Sassan, et al.
Publicado: (2016)

Epithelial-Mesenchymal Transition with Malignant Transformation Leading Multiple Metastasis from Disseminated Peritoneal Leiomyomatosis
por: Chiu, Hsiao-Chen, et al.
Publicado: (2018)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
por: Fasola, Gianpiero, et al.
Publicado: (2006)

Patients at Risk for Peritoneal Surface Malignancy of Colorectal Cancer Origin: The Role of Second Look Laparotomy
por: Brücher, Björn LDM, et al.
Publicado: (2013)

Genomic landscape of pleural and peritoneal mesothelioma tumours
por: Hiltbrunner, Stefanie, et al.
Publicado: (2022)

Multiple primary malignancies: synchronous lymphoma, pancreatic neuroendocrine tumour and colorectal cancer
por: Dayer, Nicolas, et al.
Publicado: (2021)

Peritoneal Mesothelioma in a High Volume Peritoneal Surface Malignancies Unit
por: Pereira, Fernando, et al.
Publicado: (2023)

Tumour to Tumour Metastasis of Malignant Melanoma to Intracranial Tumour
por: Shariff, Zakir, et al.
Publicado: (2009)

Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases
por: Losi, Lorena, et al.
Publicado: (2018)

Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer
por: Greystoke, A, et al.
Publicado: (2012)

Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer
por: Dilworth, Mark P., et al.
Publicado: (2019)

Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy
por: Zhang, Huan, et al.
Publicado: (2018)

Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells
por: Wei, Mingtian, et al.
Publicado: (2017)

Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis
por: Xiang, Xuemei, et al.
Publicado: (2022)

Glutathione S-transferase expression in fetal kidney and Wilms' tumour.
por: Harrison, D. J., et al.
Publicado: (1990)

Mechanisms of Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells During Peritoneal Dialysis
por: Lee, Hi Bahl, et al.
Publicado: (2007)

Transition of lymphocyte subsets in peritoneal dialysis effluent and its relationship to peritoneal damage
por: Ohashi, Atsuki, et al.
Publicado: (2021)

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
por: Mankor, Joanne M., et al.
Publicado: (2020)

Epithelial‐to‐mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition
por: McCorry, Amy MB, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g9q7mgo1cv8kno6m97f8vs3ipa